Reply to: "Evidence and choice: The BCLC vision for tailoring clinical decision-making".

导出 LinkOut

翻译打印收藏纠错

第一作者： Franco,Trevisani

第一单位： Unit of Semetiotics, Liver and Alcohol-related Disease, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Units of Semetiotics, Liver and Alcohol related disease, Alma Mater Studiorum - University of Bologna, Bologna, Italy.

作者： Franco,Trevisani ^[1] ; Alessandro,Vitale ^[2] ; Agostino,Colli ^[3] ; Masatoshi,Kudo ^[4] ; Laura,Kulik ^[5] ; Joon-Won,Park ^[6] ; David J,Pinato ^[7] ; Umberto,Cillo ^[8]

作者单位： Unit of Semetiotics, Liver and Alcohol-related Disease, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Units of Semetiotics, Liver and Alcohol related disease, Alma Mater Studiorum - University of Bologna, Bologna, Italy. ^[1] Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy. Electronic address: alessandro.vitale@unipd.it. ^[2] The Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Center for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. ^[3] Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan. ^[4] Northwestern Medicine, Chicago, IL, USA. ^[5] Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea. ^[6] Department of Surgery & Cancer, Imperial College London, London, UK; Division of Oncology, Department of Translational Medicine (DIMET), The University of Piemonte Orientale "A. Avogadro", Novara, Italy. ^[7] Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy. ^[8]

主题词人类(Humans);循证医学(Evidence-Based Medicine)

DOI 10.1016/j.jhep.2024.06.007

PMID 38871124

发布时间 2024-09-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交